Adimab(美國(guó))

Adimab

美國(guó)Adimabwww.adimab.com總部位于新罕布什爾州Lebanon的Adimab公司關(guān)注的是蛋白質(zhì)藥品。通過(guò)此次投資，GoogleVentures的比爾·麥瑞斯(BillMaris)將成為Adimab公司董事。他表示，先進(jìn)的生命科學(xué)技術(shù)是極度計(jì)算密集型，GoogleVentures將投入大量資金，幫助Adimab公司成為的抗體公司。Adimab'sintegratedan tibodydiscoveryandoptimizationplatformprovidesunprecedentedspeedfromantigentopurified,full-lengthhumanIgGs.Adimaboffersfundamentaladvantagesbydeliveringdiversepanelsoftherapeuticallyrelevantantibodiesthatmeetthemostaggressivestandardsforaffinity,epitopecoverage,speciescross-reactivityandexpressability.Adimabenablesitspartnerstorapidlyexpandtheirbiologicspipelinesthroughabroadspectrumoftechnologyaccessarrangements.Conventionalantibodydiscoveryisalengthyprocessthatinvolvesamyriadofdifferenttechnologiesthatneedtobeassembledbeforeacommercialantibodycanbeproduced.Theintegrationof:(i)librarydesign,(ii)displaymethodology,(iii)reformattingbetweendifferenth